KEPPRA injection should be administered as a 15-minute IV infusion. One vial of KEPPRA injection contains 500 mg levetiracetam (500 mg/5 mL). KEPPRA injection
The liquid Keppra solution was approved by the FDA in 2024. Liquid Injection. Image. Keppra Injection Vial. 100 mg per 1 mL (milliliters)
KEPPRA injection should be administered as a 15-minute IV infusion. One vial of KEPPRA injection contains 500 mg levetiracetam (500 mg/5 mL). KEPPRA
information for KEPPRA. injection. of KEPPRA injection should be equivalent to those of oral KEPPRA. At the end of the intravenous treatment period, the patient may be switched to . KEPPRA (levetiracetam) injection, for intravenous use . KEPPRA oral administration at the equivalent daily dosage and frequency . Initial U.S. Approval: 2024 (2.4, 2.5)
Levetiracetam 500mg, 750mg; ext-rel tabs. Pharmacological Class. Antiepileptic. See Also. KEPPRA KEPPRA ORAL SOLUTION KEPPRA INJECTION
Antiepileptic. See Also. KEPPRA KEPPRA ORAL SOLUTION KEPPRA INJECTION. How Supplied. Tabs 250mg
Keppra (levetiracetam) is an anti-epileptic. Keppra injection is specifically indicated for the following: for adjunctive therapy for the treatment of:
KEPPRA injection should be administered as a 15-minute. IV infusion. One vial of KEPPRA injection contains 500 mg levetiracetam (500 mg/5 mL). KEPPRA
Keppra is used with other medications in adults with epilepsy. What Are Side Effects of Keppra Injection? Side effects of Keppra include: drowsiness,; dizziness
Comments